Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Research

• Publication date

  2012-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-11-2651PMID 22389452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An intact retinoblastoma protein‐binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells

  2012influential reference
• miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells.

  2011cited by this paper
• Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus

  2011cited by this paper
• Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus

  2011cited by this paper
• Structural evaluation of new human polyomaviruses provides clues to pathobiology.

  2010cited by this paper
• The Human Polyoma JC Virus Agnoprotein Acts as a Viroporin

  2010cited by this paper
• Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens

  2010influential reference
• New virus associated with merkel cell carcinoma development.

  2010cited by this paper
• The Interferon Stimulated Gene 54 Promotes Apoptosis*

  2010cited by this paper
• Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis.

  2010cited by this paper
• Redefining the role of interferon in the treatment of malignant diseases.

  2010cited by this paper
• Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells

  2010cited by this paper
• Modulation of PML protein expression regulates JCV infection.

  2009influential reference
• Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha.

  2009cited by this paper
• Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma

  2009cited by this paper
• Type III IFNs: New layers of complexity in innate antiviral immunity

  2009cited by this paper
• MC polyomavirus is frequently present in Merkel cell carcinoma of European patients.

  2009cited by this paper
• Does pegylated interferon α-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?

  2009cited by this paper
• Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma

  2008cited by this paper
• Merkel cell carcinoma

  2008cited by this paper
• Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene.

  2008cited by this paper
• T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus

  2008cited by this paper
• Interferon-Alpha Inhibits Proliferation and Induces Apoptosis of Merkel Cell Carcinoma In Vitro

  2008influential reference
• [Evaluation of treatment and prognosis of Merkel cell carcinoma of the eyelid in Japan].

  2007cited by this paper
• Interferon-α and -β Restrict Polyomavirus JC Replication in Primary Human Fetal Glial Cells: Implications for Progressive Multifocal Leukoencephalopathy Therapy

  2007cited by this paper
• Interferon: cellular executioner or white knight?

  2007cited by this paper
• PML and PML nuclear bodies: implications in antiviral defence.

  2007cited by this paper
• Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.

  2007cited by this paper
• Interferon-alpha-induced apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent and -independent manner.

  2007cited by this paper
• Direct observation of individual endogenous protein complexes in situ by proximity ligation

  2006cited by this paper
• Inhibitory Effect of Gamma Interferon on BK Virus Gene Expression and Replication

  2006cited by this paper
• PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0

  2006cited by this paper
• Merkel cell carcinoma: Changing incidence trends

  2005cited by this paper
• History of modern multiple sclerosis therapy

  2005cited by this paper
• PML mediates IFN-α-induced apoptosis in myeloma by regulating TRAIL induction

  2005cited by this paper
• STAT5 contributes to interferon resistance of melanoma cells.

  2005cited by this paper
• PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.

  2005cited by this paper
• Merkel cell carcinoma

  2004cited by this paper
• Interferon-gamma: an overview of signals, mechanisms and functions.

  2004cited by this paper
• Interferon- : an overview of signals, mechanisms and functions

  2004cited by this paper
• A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

  2003cited by this paper
• Epigenetic silencing of multiple interferon pathway genes after cellular immortalization

  2003cited by this paper
• Combined karyotyping, CGH and M‐FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma

  2002cited by this paper
• DNA viruses and viral proteins that interact with PML nuclear bodies

  2001cited by this paper
• A Study of Apoptosis in Merkel Cell Carcinoma: An Immunohistochemical, Ultrastructural, DNA Ladder, and TUNEL Labeling Study

  2001cited by this paper
• Regulation of the Promoter Activity of Interferon Regulatory Factor-7 Gene

  2000cited by this paper
• Characterisation of four merkel cell carcinoma adherent cell lines

  1995cited by this paper
• Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix- associated PML bodies

  1995cited by this paper
• Merkel cell carcinoma: in vitro and in vivo characteristics of a new cell line.

  1993cited by this paper
• [Recombinant interferon alpha-2A in the treatment of HIV-associated Kaposi sarcoma. Long-term results].

  1990cited by this paper
• Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. IV. Definition of optimal treatment regimens

  1986cited by this paper
• [Long-term results].

  1983cited by this paper
• Trabecular carcinoma of the skin.

  1972cited by this paper
• Virus interference. I. The interferon

  1957cited by this paper

• IFN γ and the IFN γ Signaling Pathways in Merkel Cell Carcinoma

  2025cites this paper
• Nano-omics and Nanomedicine Target Microbial Carcinogenesis: Tumor Microenvironment Reprograming To Clinical Translation.

  2025cites this paper
• Characterization of the Impact of Merkel Cell Polyomavirus-Induced Interferon Signaling on Viral Infection

  2023cites this paper
• Longitudinal multi-functional analysis identified responses of T cells, B cells, and monocytes as hallmarks of immunotherapy tolerance in patients with merkel cell carcinoma

  2023cites this paper
• The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression

  2023cites this paper
• Merkel Cell Carcinoma—Update on Diagnosis, Management and Future Perspectives

  2022cites this paper
• High prevalence of Merkel cell polyomavirus is associated with dysregulation in transcript levels of TLR9 and type I IFNs in a large cohort of CF patients from the Italian (Lazio) reference center for cystic fibrosis.

  2022cites this paper
• Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus–Positive MCC Cell Lines

  2021cites this paper
• Virus-Induced Tumorigenesis and IFN System

  2021cites this paper
• Chapter XX Antiviral Treatment and Cancer Control.

  2021cites this paper
• T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options

  2021cites this paper
• Comparative analyses of tumorigenic mechanisms of Merkel cell polyomavirus T antigens

  2020cites this paper
• Merkel cell carcinoma and 18FDG PET-CT: A case report

  2020cites this paper
• Characterization of six Merkel cell polyomavirus‐positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration

  2019cites this paper
• Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma

  2019cites this paper
• Increasing of the interferon-γ gene expression during polyomavirus BK infection in kidney transplant patients.

  2019cites this paper
• Molecular and immune targets for Merkel cell carcinoma therapy and prevention

  2019cites this paper
• Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma

  2018cites this paper
• Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC

  2018cites this paper
• Merkel Cell Polyomavirus Small T Antigen Drives Cell Motility via Rho-GTPase-Induced Filopodium Formation

  2017cites this paper
• Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma

  2017cites this paper
• Interaction between Merkel cell carcinoma and the immune system: Pathogenetic and therapeutic implications.

  2017cites this paper
• Merkel cell polyomavirus DNA in the blood of patients with neurological diseases and healthy controls

  2017cites this paper
• Merkel cell carcinoma

  2017cites this paper
• The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6.

  2016cites this paper
• Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.

  2016cites this paper
• Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma

  2016cites this paper
• Merkel cell carcinoma: Do you know your guidelines?

  2016cites this paper
• Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma.

  2016cites this paper
• Post-transplant Merkel Cell Carcinoma.

  2016cites this paper
• Merkel cell polyomavirus-specific CD8 T cells in Merkel cell carcinoma: T cell receptor diversity & novel immune therapies

  2016cites this paper
• Large T and small T antigens of Merkel cell polyomavirus.

  2015cites this paper
• Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives.

  2015cites this paper
• Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options

  2015cites this paper
• The Role of Merkel Cell Polyomavirus and Other Human Polyomaviruses in Emerging Hallmarks of Cancer

  2015cites this paper
• Involvement of Merkel Cell Polyomavirus in the Etiology and Pathogenesis of Merkel Cell Carcinoma: A Systematic Review

  2014cites this paper
• Merkel Cell Carcinoma: Epidemiology, Target, and Therapy

  2014cites this paper
• Merkel cell carcinoma - recent advances in the biology, diagnostics and treatment.

  2014cites this paper
• Anti-viral treatment and cancer control.

  2014cites this paper
• Merkel Cell Polyomavirus: Molecular Insights into the Most Recently Discovered Human Tumour Virus

  2014cites this paper
• Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell Carcinoma

  2014cites this paper
• The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma

  2014cites this paper
• The Merkel Cell Polyomavirus and Its Involvement in Merkel Cell Carcinoma

  2013cites this paper
• Complete Spontaneous Regression of Merkel Cell Carcinoma

  2013cites this paper
• Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma

  2013cites this paper
• The Role of the Immune Response in Merkel Cell Carcinoma

  2013cites this paper
• Proposal for Publishing and Parallel Reporting of Case Reports on Adverse Drug Reactions to Authorities by Physicians

  2013cites this paper
• Merkel cell polyomavirus-specific T cell responses, immune evasion mechanisms & immune therapy in Merkel cell carcinoma

  2013cites this paper
• Human Merkel cell polyomavirus: virological background and clinical implications

  2013cites this paper
• Merkel cell carcinoma.

  2012cites this paper
• MCV and Merkel cell carcinoma: a molecular success story.

  2012cites this paper
• Trichodysplasia spinulosa-Associated Polyomavirus (TSV) and Merkel Cell Polyomavirus: Correlation between Humoral and Cellular Immunity Stronger with TSV

  2012cites this paper